Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 31 Melanoma 20 Neoplasms 13 Breast Neoplasms 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 6 Prostatic Neoplasms 4 Hodgkin Disease 4 Glioblastoma 4 Carcinoma, Transitional Cell 4 Carcinoma 4 Uterine Cervical Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Adenocarcinoma 3 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms, Squamous Cell 2 Mesothelioma 2

Interventions

tislelizumab 1 pembrolizumab 1 atezolizumab 1 Water 1 Therapeutics 1 Surgical Procedures, Operative 1 Preoperative Exercise 1 Nutritional Support 1 Immunoglobulins, Intravenous 1 Exercise 1 Ethanol 1 Dosage Forms 1 Biological Therapy 1 Adiposity 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Urologic Neoplasms × pembrolizumab × Clear all

NCT04931979 2023-03-01

Pembro-SRT

University Hospital Freiburg

Phase 2 Unknown

Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡